Kinross Gold has posted its first meaningful bounce since Q2 results — up 2.7% on Tuesday to CAD 33.18 — but the stock still trails a resurgent peer group, making the week's standout tension a question of catch-up versus laggard.
The post-earnings setup tells an interesting story when set against the broader sector. Kinross fell modestly on its Q2 print — down roughly 1.2% on the day — consistent with the cautious sector backdrop previewed in the last two notes filed here. Since then, the gold complex has swung sharply higher. Wheaton Precious Metals is up 2.7% on the week and gained 6.5% on Tuesday alone. Centerra Gold has been the star, adding nearly 10% over the past week. Barrick rose 4.5% Tuesday. Agnico Eagle gained 3.7% on the day and is up 3.2% on the week. Kinross's flat weekly performance — essentially unchanged over seven days — stands out as underperformance against a group that is broadly ripping. The stock remains down 7.9% over the past month, a hangover that peers appear to be shaking off faster.
The lending market offers no explanation for the lag — short sellers are simply not a factor here. Availability is effectively unlimited, with the borrow pool running at many multiples of outstanding short positions. Short interest is 0.91% of the free float, unchanged week-on-week and barely moved from a month ago despite a headline 24% increase over 30 days that flatters a very small base. Cost to borrow has fallen sharply — down 33% on the week and 73% over the past month — to just 0.52%. Nothing in the positioning data points to short-side pressure. The ORTEX short score is a benign 27.7, nudging higher but well within a narrow band; it ranks in the 83rd percentile for low short-squeeze risk, which in this context means shorts are not a source of either threat or support.
The fundamental picture is more nuanced. Valuation multiples have contracted meaningfully over the past month: price-to-book has fallen 0.36x in 30 days to 2.16x, and the EV/EBITDA sits at 4.1x — a lean multiple for a senior gold producer with what earlier notes described as a Piotroski F-score of 9 and a 43% year-on-year revenue increase. The earnings yield has drifted higher, and the trailing P/E at 7.8x reflects significant compression from the stock's May highs above CAD 40. Analyst data is too stale to cite. The factor scores worth flagging are the earnings momentum readings — EPS momentum over both 30 and 90 days ranks in the bottom quintile of the universe, at 13 and 19 respectively — suggesting the Street has been trimming forward estimates even as gold prices hold up. That disconnect between gold strength and estimate revisions may be doing more to hold the stock back than any positioning dynamic.
Insider activity reinforces a mild note of caution from inside the company. The COO sold roughly 27,000 shares across two tranches in late May at prices near CAD 40 to 41 — well above current levels. A Senior Vice President added a smaller sale in late June at CAD 33.35. Net insider activity over the past 90 days is marginally positive at roughly 52,000 shares, but that figure is driven by award transactions rather than open-market purchases. No C-suite buyer has stepped in near current prices. Institutionally, the ownership base is stable and concentrated in index-aware and sector-specialist hands — Van Eck holds 8.9%, BlackRock 6.7%, and several Canadian managers have added modestly through June. The holder base is not a source of instability, but it is also not signalling fresh conviction.
The next event on the calendar is the Q3 results, pencilled in for late October. Between now and then, the key variable is whether Kinross closes the performance gap with peers — the gap opened over the past month and widened further this week despite Tuesday's bounce — or whether the lagging EPS revisions continue to suppress re-rating even as bullion holds its bid.
See the live data behind this article on ORTEX.
Open K on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
